| 2014 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. | Li, J; Lindstrom, LS; Foo, JN; Rafiq, S; Schmidt, MK; Pharoah, PD; Michailidou, K; Dennis, J; Bolla, MK; Wang, Q; Van’t Veer, LJ; Cornelissen, S; Rutgers, E; Southey, MC; Apicella, C; Dite, GS; Hopper, JL; Fasching, PA; Haeberle, L; Ekici, AB; Beckmann, MW; Blomqvist, C; Muranen, TA; Aittomaki, K; Lindblom, A; Margolin, S; Mannermaa, A; Kosma, VM; Hartikainen, JM; Kataja, V; Chenevix-Trench, G; Phillips, KA; McLachlan, SA; Lambrechts, D; Thienpont, B; Smeets, A; Wildiers, H; Chang-Claude, J; Flesch-Janys, D; Seibold, P; Rudolph, A; Giles, GG; Baglietto, L; Severi, G; Haiman, CA; Henderson, BE; Schumacher, F; Le Marchand, L; Kristensen, V; Alnaes, GI; Borresen-Dale, AL; Nord, S; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Andrulis, IL; Knight, JA; Glendon, G; Tchatchou, S; Devilee, P; Tollenaar, R; Seynaeve, C; Hooning, M; Kriege, M; Hollestelle, A; van den Ouweland, A; Li, Y; Hamann, U; Torres, D; Ulmer, HU; Rudiger, T; Shen, CY; Hsiung, CN; Wu, PE; Chen, ST; Teo, SH; Taib, NA; Har Yip, C; Fuang Ho, G; Matsuo, K; Ito, H; Iwata, H; Tajima, K; Kang, D; Choi, JY; Park, SK; Yoo, KY; Maishman, T; Tapper, WJ; Dunning, A; Shah, M; Luben, R; Brown, J; Khor, CC; Eccles, DM; Nevanlinna, H; Easton, D; Humphreys, K; Liu, J; Hall, P; Czene, K | Nature communications 5, 4051 | | | |
